Influence of very long-chain n-3 fatty acids on plasma markers of inflammation in middle-aged men

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 78, Issue 3, 2008, Pages 219-228

  Yusof, Hayati M ^a   Miles, Elizabeth A ^a   Calder, Philip ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INTERCELLULAR ADHESION MOLECULE 1; LIPID; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; PLACEBO; TRIACYLGLYCEROL;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MIDDLE AGED;

EID: 41949141765     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2008.02.002     Document Type: Article

References (70)

1. British Nutrition Foundation. Task Force Report-Cardiovascular Disease: Diet, Nutrition and Emerging Risk Factors (2005), Blackwell, Oxford
2. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
3. Glass C.K., and Witztum J.L. Atherosclerosis: the road ahead. Cell 104 (2001) 503-516
4. Gearing A.J.H., and Newman W. Circulating adhesion molecules in disease. Immunol. Today 14 (1993) 506-512
5. Morisaki N., Saito I., Tamura K., Tashiro J., Masuda M., Kanzaki T., Watanabe S., Masuda Y., and Saito Y. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis 131 (1997) 43-48
6. Haught W.H., Mansour M., Rothlein R., Kishimoto T.K., Mainolfi E.A., Hendricks J.B., Hendricks C., and Mehta J.L. Alterations in circulating intercellular adhesion molecule-1 and l-selectin: further evidence for chronic inflammation in ischemic heart disease. Am. Heart J. 132 (1996) 1-8
7. Ridker P.M., Hennekens C.H., Roitman-Johnson B., Stampfer M.J., and Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351 (1998) 88-92
8. Blake G.J., and Ridker P.M. Novel clinical markers of vascular wall inflammation. Circ. Res. 89 (2001) 763-771
9. Kromhout D., Bosschieter E.B., and Coulander C.L. The inverse relationship between fish consumption and 20-year mortality from coronary heart disease. N. Engl. J. Med. 312 (1985) 1205-1209
10. Shekelle R.B., Missell L., Paul O., Shryock A.M., and Stamler J. Fish consumption and mortality from coronary heart disease. N. Engl. J. Med. 313 (1985) 820
11. Norell S., Ahlbom A., Feychling M., and Pedersen N.L. Fish consumption and mortality from coronary heart disease. Br. Med. J. 293 (1986) 426
12. Daviglus M.L., Stamler J., Orencia A.J., Morris D., and Shekelle R.B. Fish consumption and the 30-year risk of fatal myocardial infarction. N. Engl. J. Med. 336 (1997) 1046-1053
13. Albert C.M., Hennekens C.H., O'Donnell C.J., Ajani U.A., Carey V.J., and Willett W.C. Fish consumption and risk of sudden cardiac death. J. Am. Med. Assoc. 279 (1998) 23-28
14. Hu F.B., Bronner L., Willett W.C., Stampfer M.J., Rexrode K.M., Albert C.M., Hunter D., and Manson J.E. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. J. Am. Med. Assoc. 287 (2002) 1815-1821
15. Iso H., Rexrode K.M., Stampfer M.J., Manson J.E., Colditz G.A., Speizer F.E., Hennekens C.H., and Willett W.C. Intake of fish and omega-3 fatty acids and risk of stroke in women. J. Am. Med. Assoc. 285 (2001) 304-312
16. He K., Rimm E.B., Merchant A., Rosner B.A., Stampfer M.J., Willett W.C., and Ascherio A. Fish consumption and risk of stroke in men. J. Am. Med. Assoc. 288 (2002) 3130-3136
17. Gillum R.F., Mussolino M.E., and Madans J.H. The relationship between fish consumption and stroke incidence: The NHANES I Epidemiologic Follow-up Study. Arch. Intern. Med. 156 (1996) 537-542
18. Dolecek T.A. Epidemiologic evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial. Proc. Soc. Exp. Biol. Med. 200 (1982) 177-182
19. Siscovick D.S., Raghunathan T.E., King I., Weinmann S., Wicklund K.G., Albright G.J., Bovbjerg V., Arbogast P., Smith H., Kushi L.H., Cobb L.A., Copass M.K., Psaty B.M., Lemaitre R., Retzlaff B., Childs M., and Knopp R.H. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. J. Am. Med. Assoc. 274 (1995) 1363-1367
20. Pedersen J.I., Ringstad J., Almendingen K., Haugen T.S., Stensvold I., and Thelle D.S. Adipose tissue fatty acids and risk of myocardial infarction-a case-control study. Eur. J. Clin. Nutr. 54 (2000) 618-625
21. Albert C.M., Campos H., Stampfer M.J., Ridker P.M., Manson J.A., Willett W.C., and Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 346 (2002) 1113-1118
22. Lemaitre R.N., King I.B., Mozaffarian D., Kuller L.H., Tracy R.P., and Siscovick D.S. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: The Cardiovascular Health Study. Am. J. Clin. Nutr. 77 (2003) 319-325
23. Kris-Etherton P.M., Harris W.S., and Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. American Heart Association Nutrition Committee. Circulation 106 (2002) 2747-2757
24. Calder P.C. N-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin. Sci. 107 (2004) 1-11
25. von Schacky C. Omega-3 fatty acids and cardiovascular disease. Curr. Opin. Clin. Nutr. Metab. Care 7 (2004) 131-136
26. Calder P.C. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36 (2001) 1007-1024
27. Calder P.C. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38 (2003) 342-352
28. Calder P.C. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 83 (2006) 1505S-1519S
29. Calder P.C. Polyunsaturated fatty acids and inflammation. Prost. Leuk. Essent. Fatty Acids 75 (2006) 197-202
30. De Caterina R., Cybulsky M.I., Clinton S.K., Gimbrone M.A., and Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler. Thromb. 14 (1994) 1829-1836
31. Khalfoun B., Thibault G., Bardos P., and Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyte-endothelial cell adhesion. Transplantation 62 (1996) 1649-1657
32. Weber C., Erl W., Pietsch A., Danesch U., and Weber P.C. Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-alpha. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 622-628
33. Collie-Duguid E.S.R., and Wahle K.W.J. Inhibitory effect of fish oil n-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem. Biophys. Res. Commun. 220 (1996) 969-974
34. Hughes D.A., Southon S., and Pinder A.C. (n-3) Polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro. J. Nutr. 126 (1996) 603-610
35. Miles E.A., Wallace F.A., and Calder P.C. Dietary fish oil reduces intercellular adhesion molecule 1 and scavenger receptor expression on murine macrophages. Atherosclerosis 152 (2000) 43-50
36. Sanderson P., and Calder P.C. Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial cell monolayers. Immunology 94 (1998) 79-87
37. Hughes D.A., Pinder A.C., Piper Z., Johnson I.T., and Lund E.K. Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am. J. Clin. Nutr. 63 (1996) 267-272
38. Miles E.A., Thies F., Wallace F.A., Powell J.R., Hurst T.L., Newsholme E.A., and Calder P.C. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin. Sci. 100 (2001) 91-100
39. Seljeflot I., Arnesen H., Brude I.R., Nenseter M.S., Drevon C.A., and Hjermann I. Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers. Eur. J. Clin. Invest. 28 (1998) 629-635
40. Abe Y., El-Masri B., Kimball K.T., Pownall H., Reilly C.F., Osmundsen K., Smith C.W., and Ballantyne C.M. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 723-731
41. Johansen O., Seljeflot I., Hostmark A.T., and Arnesen H. The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1681-1686
42. Scientific Advisory Committee on Nutrition/Committee on Toxicity. Advice on Fish Consumption; Benefits and Risks (2004), TSO, London
43. British Nutrition Foundation. N-3 Fatty Acids and Health (1999), British Nutrition Foundation, London
44. Burdge G.C., Wright P., Jones A.E., and Wootton S.A. A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br. J. Nutr. 84 (2000) 781-787
45. Yaqoob P., Pala H.S., Cortina-Borja M., Newsholme E.A., and Calder P.C. Encapsulated fish oil enriched in α-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur. J. Clin. Invest. 30 (2000) 260-274
46. Wallace F.A., Miles E.A., and Calder P.C. Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects. Br. J. Nutr. 89 (2003) 679-689
47. Tholstrup T., Ehnholm C., Jauhiainen M., Petersen M., Hoy C.E., Lund P., and Sandstrom B. Effects of medium-chain fatty acids and oleic acid on blood lipids, lipoproteins, glucose, insulin, and lipid transfer protein activities. Am. J. Clin. Nutr. 79 (2004) 564-569
48. Appel L.J., Miller E.R., Seidler A.J., and Whelton P.K. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch. Intern. Med. 153 (1993) 1429-1438
49. Geleijnse J.M., Giltay E.J., Grobbee D.E., Donders A.R., and Kok F.J. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J. Hypertens. 20 (2002) 1493-1499
50. Katan M.B., Zock P.L., and Mensink R.P. Dietary oils, serum lipoproteins, and coronary heart disease. Am. J. Clin. Nutr. 61 (1995) 1368S-1373S
51. Harris W.S. N-3 fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65 (1997) 1645S-1654S
52. Kris-Etherton P.M., and Yu S. Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am. J. Clin. Nutr. 65 (1997) 1628S-1644S
53. Cater N.B., Heller H.J., and Denke M.A. Comparison of the effects of medium-chain triacylglycerols, palm oil, and high oleic acid sunflower oil on plasma triacylglycerol fatty acids and lipid and lipoprotein concentrations in humans. Am. J. Clin. Nutr. 65 (1997) 41-45
54. Roche H.M. Unsaturated fatty acids. Proc. Nutr. Soc. 58 (1999) 397-401
55. Hamazaki T., Sawazaki S., Asaoka E., Itomura M., Mizushima Y., Yazawa K., Kuwamori T., and Kobayashi M. Docosahexaenoic acid-rich fish oil does not affect serum lipid concentrations of normolipidemic young adults. J. Nutr. 126 (1999) 2784-2789
56. Grimsgaard S., Bonaa K.H., Hansen J.B., and Myhre E.S. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am. J. Clin. Nutr. 68 (1998) 52-59
57. Mori T.A., Burke V., Puddey I.B., Watts G.F., O'Neal D.N., Best J.D., and Beilin L.J. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am. J. Clin. Nutr. 71 (2000) 1085-1094
58. Woodman R.J., Mori T.A., Burke V., Puddey I.B., Watts G.F., and Beilin L.J. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am. J. Clin. Nutr. 76 (2002) 1007-1015
59. Buckley R., Shewring B., Turner R., Yaqoob P., and Minihane A.M. Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects. Br. J. Nutr. 92 (2004) 477-483
60. Yamamoto H., Yoshimura H., Noma M., Suzuki S., Kai H., Tajimi T., Sugihara M., and Kikuchi Y. Improvement of coronary vasomotion with eicosapentaenoic acid does not inhibit acetylcholine-induced coronary vasospasm in patients with variant angina. Jpn. Circ. J. 59 (1995) 608-616
61. Conquer J.A., and Holub B.J. Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. J. Lipid Res. 39 (1998) 286-292
62. Ciubotaru I., Lee Y.S., and Wander R.C. Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J. Nutr. Biochem. 14 (2003) 513-521
63. Geelen A., Brouwer I.A., Schouten E.G., Kluft C., Katan M.B., and Zock P.L. Intake of n-3 fatty acids from fish does not lower serum concentrations of C-reactive protein in healthy subjects. Eur. J. Clin. Nutr. 58 (2004) 1440-1442
64. Mori T.A., Woodman R.J., Burke V., Puddey I.B., Croft K.D., and Beilin L.J. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic. Biol. Med. 35 (2003) 772-781
65. Madsen T., Christensen J.H., Blom M., and Schmidt E.B. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br. J. Nutr. 89 (2003) 517-522
66. Berstad P., Seljeflot I., Veierod M.B., Hjerkinn E.M., Arnesen H., and Pedersen J.I. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1. Clin. Sci. 105 (2003) 13-20
67. Hjerkinn E.M., Seljeflot I., Ellingsen I., Berstad P., Hjermann I., Sandvik L., and Arnesen H. Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am. J. Clin. Nutr. 81 (2005) 583-589
68. Abbate R., Gori A.M., Martini F., Brunelli T., Filippini M., Francalanci I., Paniccia R., Prisco D., Gensini G.F., and Neri Serneri G.G. n-3 PUFA supplementation, monocyte PCA expression and interleukin-6 production. Prost. Leukot. Essent. Fatty Acids 54 (1996) 439-444
69. Trebble T., Arden N.K., Stroud M.A., Wootton S.A., Burdge G.C., Miles E.A., Ballinger A.B., Thompson R.L., and Calder P.C. Inhibition of tumour necrosis factor-alpha and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Br. J. Nutr. 90 (2003) 405-412
70. Yli-Jama P., Seljeflot I., Meyer H.E., Hjerkinn E.M., Arnesen H., and Pedersen J.I. Serum non-esterified very long-chain PUFA are associated with markers of endothelial dysfunction. Atherosclerosis 164 (2002) 275-281